4.2 Article

Diazepam Monotherapy or Diazepam-Ketamine Dual Therapy at Different Time Points Terminates Seizures and Reduces Mortality in a Status Epilepticus Animal Model

Journal

MEDICAL SCIENCE MONITOR
Volume 27, Issue -, Pages -

Publisher

INT SCIENTIFIC INFORMATION, INC
DOI: 10.12659/MSM.934043

Keywords

Diazepam; Duration of Therapy; Ketamine; Status Epilepticus; Treatment Outcome

Funding

  1. Hospital Project of the Affiliated Hospital of North Sichuan Medical College [2020JC024]
  2. strategic cooperation grant of science and technology between Nanchong city and College [19SXHZ0105]

Ask authors/readers for more resources

Diazepam monotherapy can terminate seizures and improve survival rates within 10 minutes of SE onset, while diazepam-ketamine dual therapy can terminate seizures and achieve high survival rates when SE lasts more than 10 minutes but less than 30 minutes.
Background: Being refractory to drugs remains an urgent treatment problem in status epilepticus (SE). The fact that gamma-amino- butyric acid A receptors (GABA(A) Rs) become internalized and inactive, N-methyl-D-aspartate receptors (NMDARs) become externalized and active during SE may explain the refractoriness to benzodiazepine. However, the real-time dynamic efficacy of antiepileptic drugs remains unclear. Therefore, we propose a hypothesis that diazepam monotherapy or diazepam-ketamine dual therapy could terminate seizures and reduce mortality in the SE model at different time points during ongoing SE. Material/Methods: An SE model was established in adult Sprague-Dawley rats with lithium and pilocarpine. The GABA(A) R agonist diazepam was injected at 5, 10, 20, or 30 min when SE continued. In addition, diazepam and the NMDAR antagonist ketamine were injected at 10 to 60 min at 6 different time points. We measured seizure-free rates, seizure duration, degree of behavioral seizure, and mortality. Results: Diazepam monotherapy at 5 min and 10 min from the beginning of SE was able to terminate seizures and improved survival rates. Diazepam-ketamine dual therapy at 10 min, 20 min, and 30 min from the beginning of SE terminated seizures and achieved high survival rates. Conclusions: In this parallel randomized controlled trial with a rat model, we found that diazepam monotherapy was an effective antiepileptic strategy at the early stage of SE less than 10 min after SE onset. If SE lasts more than 10 min but less than 30 min, the diazepam-ketamine dual therapy strategy may be an appropriate choice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available